Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. - Wikidata - wikimedia - TriplyDB

Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999.

Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999.

http://www.wikidata.org/entity/Q37320170

about

Resistance to antimicrobials in humans and animals Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic.Risk factors for antibiotic-resistant E. coli in children in a rural area.The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period.Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus Can better prescribing turn the tide of resistance?Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy Therapeutic implications of macrolide resistance in pneumococcal community-acquired lower respiratory tract infections.Epidemiological interpretation of antibiotic resistance studies - what are we missing?Update on treatment guidelines for acute bacterial sinusitis.Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices Update on management of infections in cancer and stem cell transplant patients.Association between antimicrobial consumption and resistance in Escherichia coli.Characterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China.Medicinal potential of ciprofloxacin and its derivatives.Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001.In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therap Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy.Multiple Antimicrobial Resistance of Escherichia coli Isolated from Chickens in Iran Emergency hospital admissions attributable to infective complications of prostate biopsy despite appropriate prophylaxis: need for additional infection prevention strategies?Surveillance of Diarrheagenic Escherichia coli Strains Isolated from Diarrhea Cases from Children, Adults and Elderly at Northwest of Mexico.Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF.Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance.Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts.Resistance in Enterobacteriaceae: results of a multicenter surveillance study, 1995-2000.Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.Correlation between antibiotic use and resistance in a hospital: temporary and ward-specific observations.Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy.Quinolone prophylaxis in transrectal ultrasound guided prostate biopsy: an eight-year single center experience.Temporal association between antibiotic use and resistance in at a tertiary care hospital

P2860

Q24534725-3354B4A9-C73E-4386-98D9-24E16F4B9898 Q24791698-A6FCCB45-6940-4492-9B81-259085C24C26 Q30425667-3A9650FE-96BA-4059-9D57-81778F4EE392 Q33737692-0DEF258E-BA1C-4F25-B0A3-EB6256E320C0 Q34141233-C48B397C-96C7-48AF-873B-BC9A0AA7A8B9 Q34309613-78270177-D4E0-4C42-B935-EEEE6FD7578E Q34354019-8ADD7114-F66C-4CCE-BFF8-D4E62370A8E0 Q34680578-51CF2439-B76A-40D7-AC0E-80CE53B8DF1B Q35701625-4EE66D59-3DC9-4406-B11C-AD707E59CB6A Q35715463-6F09D0E2-9A60-4F45-A62B-909D02279B24 Q35890029-22D44DB5-A0E1-4E84-9768-2E03D92C4C16 Q35954276-E68EDC1F-BB10-4B88-9C52-2E7EEF2DA903 Q36107922-719C416D-D10B-41F4-8D2B-E6748FCF760A Q36296390-4E4FC823-7782-44C7-8AB0-E5457E1A3B20 Q36419298-F19EDF51-2A29-4E3E-A1B0-6329DD9984BA Q37115726-8CA3BFF8-94FC-4530-824C-5AFCDE3AE2A3 Q37157491-423A81D2-F7E4-45BE-A73F-7F2DF0A520D4 Q38068970-CB3CAC56-41B2-4D88-AF5D-14A1D9128BE2 Q39015906-074CC9FC-FDA6-4B7C-BA6F-6F73A9B6D77E Q39746439-3F4EED12-D540-4A1F-BC71-0B7BC429A0F2 Q39913204-1A24706A-2C59-40E9-AE39-6D0E8FE2583F Q40298928-E5B52C2D-E550-4328-9868-78F44F6DFC03 Q41576393-C40D8166-46CE-463B-88EB-4BF895C2BCCB Q41967821-E3D51FEF-1D02-4761-8493-E7B7382558FA Q42362007-CD1635E0-D68F-4DD7-BA60-DB4E56D3D87F Q42637997-BF43C305-2E14-483F-B5DA-10B74CA58458 Q42708760-372A2FDD-68A6-47F9-9829-DD991C7B84B0 Q43110171-22BFC997-2D7E-4AFE-B72F-827D9B41A2C2 Q44549638-E6ED17D5-6F4C-41F0-9222-9492F4F16744 Q44563019-9D11EAB0-FCE2-4C6E-8B2B-BE9CB2949F3F Q44596874-289C06A7-85F5-4810-BE12-4C3905F65F5A Q45252185-34654BBB-CFF9-41CC-990F-7FA13B3A3243 Q45981760-91726CE9-966F-487D-802A-BFD9B71D1B96 Q46687276-994BE4A5-8039-4449-B17D-E044D3E80C81 Q51237342-10191E5B-129E-4E2E-AD95-B37274787AA1 Q56517426-F814FBDC-0150-41E9-B6C8-6EC097D370DB

P2860

Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999.

http://www.wikidata.org/entity/Q37320170

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2002

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Trends in fluoroquinolone (cip ...... England and Wales, 1990-1999.

@en

Trends in fluoroquinolone (cip ...... England and Wales, 1990-1999.

@nl

type

label

Trends in fluoroquinolone (cip ...... England and Wales, 1990-1999.

@en

Trends in fluoroquinolone (cip ...... England and Wales, 1990-1999.

@nl

prefLabel

Trends in fluoroquinolone (cip ...... England and Wales, 1990-1999.

@en

Trends in fluoroquinolone (cip ...... England and Wales, 1990-1999.

@nl

P1433

Q37320170-51507824-539A-4289-A65A-79FD2F3D44FF

P1476

Q37320170-2A44B296-104C-47F2-B46D-46D75C579541

P2093

Q37320170-201A1B27-F454-4921-B870-B5B9380C660F

Q37320170-2033D96F-23E6-4F9A-B536-890964376D66

Q37320170-5799F7A4-3894-45C3-8E95-CD7DA736CA01

Q37320170-5FE01FAC-3E30-4677-9840-CE92A3E31B41

Q37320170-82F0EC15-48B6-45A1-8F80-9354B6EFC27E

Q37320170-9190A9E5-BE66-4A25-AB8F-288BEDACC00C

Q37320170-995C7713-76CD-446C-9A26-0525CB6F2A72

Q37320170-D4AABEB2-D0F5-4A38-B7E5-6C5D52DC872A

P2860

Q37320170-2416A6CF-6614-4B22-8016-12524EEA7EC0

Q37320170-2B74EFE3-7598-4A51-B60B-79EC6A003855

Q37320170-2FE7DD00-7F50-4717-89B6-E74D619B3E2E

Q37320170-35120245-7542-4AFD-B0E9-55B7CA41E356

Q37320170-360D1213-6E2B-49D2-9F78-CFBF5556E76D

Q37320170-4BB17B48-C7EB-43CB-9547-7A18E0DF369D

Q37320170-784482DF-7605-4E79-AAFA-3665B6D89D53

Q37320170-896D2487-7249-4681-AFD7-AA2222863784

Q37320170-8FB59DB7-F31C-4BA8-98E3-75EB35C3272D

Q37320170-ADC78763-7F84-41F7-B292-113150CCC796

P304

Q37320170-BCD78AFD-3007-4871-858B-F43693601C8D

P31

Q37320170-DBCE2F56-C494-440F-ACEC-201A48D97FE8

P356

Q37320170-98388F88-3FE6-4B27-B645-E704CA9970D0

P433

Q37320170-D842220B-3434-4C69-A638-FDBE5029BCC2

P478

Q37320170-ACFC0FB4-EF81-403C-ACD1-D4DE29D255B3

P577

Q37320170-1885DC48-DAA0-418B-A87B-DB55085F05F3

P5875

Q37320170-4BA991BE-F50B-4373-B4D5-ABCE4332A8C8

P698

Q37320170-0E1654AD-5C3E-45C4-A464-A6FCB4AFF9E0

P932

Q37320170-672D016E-2AA8-48E8-9E8D-7C06F0726908

P356

P1433

Emerging Infectious Diseases

P1476

Trends in fluoroquinolone (cip ...... England and Wales, 1990-1999.

@en

P2093

Alan P Johnson

http://www.w3.org/2001/XMLSchema#string

Catriona Graham

http://www.w3.org/2001/XMLSchema#string

David M Livermore

http://www.w3.org/2001/XMLSchema#string

Dorothy James

http://www.w3.org/2001/XMLSchema#string

Mark Reacher

http://www.w3.org/2001/XMLSchema#string

Peter Stephens

http://www.w3.org/2001/XMLSchema#string

Robert C George

http://www.w3.org/2001/XMLSchema#string

Thomas Nichols

http://www.w3.org/2001/XMLSchema#string

P2860

Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing.

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria.

Emergence and dissemination of quinolone-resistant Escherichia coli in the community.

Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis.

The mode of action of 4-quinolones and possible mechanisms of resistance.

Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.

Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea.

Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin.

P304

473-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID0805.010204

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11373410

http://www.w3.org/2001/XMLSchema#string

P698

11996681

http://www.w3.org/2001/XMLSchema#string

P932

2732494

http://www.w3.org/2001/XMLSchema#string